Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Total Non-Current Liabilities: 2021-2024

Historic Total Non-Current Liabilities for ProQR Therapeutics N.V (PRQR) over the last 4 years, with Dec 2024 value amounting to $43,274.

  • ProQR Therapeutics N.V's Total Non-Current Liabilities fell 13.94% to $39,914 in Q3 2025 from the same period last year, while for Sep 2025 it was $39,914, marking a year-over-year decrease of 13.94%. This contributed to the annual value of $43,274 for FY2024, which is 35.78% down from last year.
  • Latest data reveals that ProQR Therapeutics N.V reported Total Non-Current Liabilities of $43,274 as of FY2024, which was down 35.78% from $67,380 recorded in FY2023.
  • In the past 5 years, ProQR Therapeutics N.V's Total Non-Current Liabilities ranged from a high of $85.3 million in FY2022 and a low of $43,274 during FY2024.
  • Moreover, its 3-year median value for Total Non-Current Liabilities was $67,380 (2023), whereas its average is $28.5 million.
  • As far as peak fluctuations go, ProQR Therapeutics N.V's Total Non-Current Liabilities rose by 4.89% in 2022, and later slumped by 99.92% in 2023.
  • Over the past 4 years, ProQR Therapeutics N.V's Total Non-Current Liabilities (Yearly) stood at $81.4 million in 2021, then climbed by 4.89% to $85.3 million in 2022, then tumbled by 99.92% to $67,380 in 2023, then slumped by 35.78% to $43,274 in 2024.